InfuSystem (INFU) Paperless Solutions Enhance Efficiency

MADISON HEIGHTS, Mich., April 14, 2011 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services, today announced the availability of its secure, compliant, paperless solutions. These new solutions allow facilities to create physician work order forms and view treatment logs and patient information. InfuSystem paperless offerings work with customer’s existing workflow and systems and can be accessed anywhere, anytime, from any internet-enabled device.

Customers can increase efficiency by reducing time spent completing traditional paper forms. The process is simplified by linking information across forms and allowing users to add comments and submit corrections instantly. “Reducing the use of paper forms is an important initiative for our customers. We’ve taken the time to develop a paperless system that’s both easy to use and fulfills payers’ documentation and compliance requirements. We’re confident our offering is the most flexible, secure and compliant paperless solution available,” says Sean McDevitt, Chairman and CEO of InfuSystem.

Paperless solutions from InfuSystem are customizable and available across platforms and devices. The secure system protects the privacy of patient data and adheres to patient data compliance regulations. Gaining access to InfuSystem paperless solutions is simple–registration can be done on the website and customers can be up and running quickly. “We’ve found the system to be very intuitive, and the support team has been extremely responsive to our needs. It’s the same service and innovation we’ve come to expect from InfuSystem,” stated Marie Garcia, RN OCN, Director of Clinical Services at Virginia Cancer Specialists.

About InfuSystem Holdings, Inc.

InfuSystem is the leading provider of infusion pumps and related services. InfuSystem services hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada.

Clearfield (CLFD) Ensures Fiber Protection With Enclosure Line Optimized for Optical Protection

MINNEAPOLIS, April 14, 2011 (GLOBE NEWSWIRE) — Clearfield, Inc. (Nasdaq:CLFD – News), the specialist in fiber management solutions for Fiber to the Premise (FTTp) deployments, is providing an optimized optical protection system with CraftSmart — a full line of above- and below-grade field enclosures. The CraftSmart Fiber Protection Pedestals (FPP) and CraftSmart Fiber Protection Vaults (FPV) are integrated solutions, optimized to house the FieldSmart Small Count Delivery (SCD) Case at the last mile access point of the network in above-grade or below-grade installations.

The combined solution provides an “any application, any media, anywhere” approach to the unique challenges of delivering the last mile drop. The Fiber Protection Vaults (FPV) will also support integration of Clearfield’s FieldSmart Fiber Scalability Center OSP cabinets and traditional splice point slack and closure storage. The CraftSmart line is RUS-listed and is currently shipping.

Integrated Design

“Retrofitting legacy copper solutions in the field is expensive and time-consuming,” explains Johnny Hill, chief operating officer for Clearfield. “Clients have asked for an OSP environmental enclosure line that could reduce the cost of field deployment by providing complete hardware compatibility. CraftSmart optimizes fiber protection and storage while ensuring industry standards. Utilizing tried-and-true methods of sealing and below-grade protection, along with that Clearfield innovation, we have developed a complete, turn-key solution for the deployment of passive optics from the central office/head-end to the customer premise.”

Product Details

The CraftSmart Fiber Protection Pedestal is the industry’s most cost-effective thermoplastic enclosure system featuring a full complement of standard features, including a self-locking security cover and factory installed bracketry. CraftSmart Pedestals are available in two sizes – 9″ x 22″ and 10″ x 24″ – providing maximum work space and bend radius provisions for all passive cables and connectors.

The CraftSmart Fiber Protection Vaults lead the way with 1730, 2436, and 3048 sizes that set new performance standards for below-grade thermoplastic enclosures. Utilizing a straight vertical design that supports the cover’s load across the entire vault, sidewall deflection is neutralized with a high-rib design for utilization in a variety of environments including greenbelt. A factory installed stud system on the interior wall allows for a variety of accessories from storage racks, horizontal brackets, and a two-position swing-arm for mounting Clearfield’s FieldSmart SCD Case onto for easy access and storage.

Video Presentation Available

To learn more about CraftSmart Fiber Protection, an informational video can be viewed at http://www.clearfieldconnection.com/resource-center/demonstration-videos/.

About Clearfield, Inc.

Clearfield, Inc. sets the standard for fiber performance with FiberDeep, while lowering the cost of broadband deployment with the FieldSmart fiber management platform and the CraftSmart OSP enclosure system. FieldSmart is the only fiber management platform to be designed around a single architecture — the Clearview Cassette and xPAK– for the inside plant, outside plant and access network. Scaling from 1 to 1728 ports, FieldSmart supports a wide range of panel and cabinet configurations, densities, connectors and adapter options, and are offered alongside an assortment of passive optical components. CraftSmart is the industry’s only field enclosure system optimized for fiber deployment. FiberDeep is a new class of fiber patch cords that guarantees performance at .2dB insertion loss — fully half that of the industry standard. Clearfield provides a complete line of fiber and copper assemblies for inside plant, outside plant and access networks. Clearfield is a public company traded on NASDAQ: CLFD.

CDC Global Services (CHINA) and Zhangzhou Development Zone Plan to Invest in High-Tech Food Processing Park

Independent Report Concludes CAMAC Energy, Inc.’s (CAK) OML 120 & 121 Blocks Host Substantial Quantities of Oil

CAMAC Energy Inc., a U.S.-based energy company focused on exploring for, developing and producing oil and gas, was excited to announce today the results of an independent engineering report prepared by Netherland, Sewell & Associates, Inc. (NSAI) for the purpose of estimating the total resource in place at the OML 120 & 121 Blocks situated offshore Nigeria.

The report concluded that the best estimate for gross undiscovered original oil-in-place for OML 120 & 121 is 1.9 billion barrels with a high of 6.3 billion barrels; and the best estimate for associated recoverable gross contingent and unrisked prospective oil resources is 626 million barrels with a high of 2.2 billion barrels. This is substantially greater than the estimated 500 million barrels of potential recoverable oil stated in the company’s recent investor presentation.

“We are pleased to receive this report on resources for the OML 120 & 121 Blocks,” commented Dr. Kase Lawal, Chairman and Chief Executive of CAMAC Energy. “This report clearly supports the potential we see in the two blocks and we are excited about the results. OML 120 & 121 are in a known hydrocarbon province, have existing production, extensive 3D seismic coverage and over a dozen identified prospects and leads. Together with ENI, the technical operator of OML 120 & 121, we will now work towards testing the greater potential of this play, including the deeper Miocene zone.”

The NSAI report, with further information and qualifications, can be found on CAMAC Energy’s website at www.camacenergy.com in the Investor Relations section.

BioTime (BTX) Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology

TOFUTTI (TOF) Announces 2010 Results

Intervest Bancshares Corp. (IBCA) Reports 2011 First Quarter Earnings of $1.7 Million

Sigma-Aldrich Corp. (SIAL) Division and Kraig Biocraft Laboratories, Inc. (KBLB) to Collaborate for the Production of Spider Silk

Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich, announced this morning that it has signed an agreement with Kraig Biocraft Laboratories, Inc. to develop genetically modified silkworms for the production of spider silk, using its proprietary CompoZr Zinc Finger Nuclease (ZFN) technology. Transferring silk genes from the spider to the silkworm is anticipated to allow the mass production of stronger silk with enhanced elasticity. Potential applications include sutures, tendon and ligament repair, bulletproof vests, and automobile airbags.

Since the first published sequence of a spider silk gene over twenty years ago, much research has focused on the production of commercially viable spider silk with high tensile strength and elasticity. Last year Kraig Biocraft made an important advance by producing hybrid silkworms with randomly inserted spider silk genes, yielding hybrid spider­silkworm silk with greater strength and durability than native silkworm silk. The precise gene targeting and high efficiency of Sigma’s ZFN technology enables Kraig Biocraft to build on its success by concomitantly targeting the insertion of spider silk genes into the silkworm genome while removing endogenous silkworm silk genes. The resulting transgenic silkworm is believed to be capable of spinning pure spider silk at commercially viable production levels.

“ZFN technology has been revolutionary in genome engineering for various applications, including animal models of disease, engineering of biopharmaceutical production systems, academic research and therapeutics,” stated Dr. Joseph Bedell, Director of Sigma Life Science’s Commercial Animal Technologies Group. “Spider silk production is just the first example of a potential commercial animal application for this exciting technology, perfectly positioning Sigma Life Science as a leading provider of innovative technologies that are changing the face of science and improving the quality of life.”

Cytokinetics (CYTK) Announces Data From Phase IIa “Evidence of Effect” Clinical Trial of CK-2017357

SOUTH SAN FRANCISCO, CA — (Marketwire) — 04/11/11 — Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that an oral presentation of results from its Phase IIa “Evidence of Effect” (EoE) clinical trial of CK-2017357 in patients with amyotrophic lateral sclerosis (ALS) is scheduled to be presented as part of the Clinical Trials Session at the 63rd Annual Meeting of the American Academy of Neurology, to be held April 9-16, 2011 in Honolulu, Hawaii. CK-2017357, a fast skeletal muscle troponin activator, is the lead drug candidate from the company’s skeletal muscle contractility program and the subject of a Phase IIa clinical trials program in patients with ALS, in patients with symptoms of claudication associated with peripheral artery disease, and in patients suffering from myasthenia gravis.

Oral Presentation at the 63rd Annual Meeting of the American Academy of Neurology

Date: Friday, April 15, 2011

Time: 12:15 PM Hawaii-Aleutian Standard Time

Session: 2011 Clinical Trials Session

Location: Hawaii Convention Center in Honolulu, Hawaii

Title: A Phase 2A, Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Study of the Selective Fast Skeletal Muscle Troponin Activator, CK-2017357, in Patients with ALS

Presenter: Jeffrey M. Shefner, M.D., Ph.D., Professor and Chair, Department of Neurology at the Upstate Medical University, State University of New York

About Cytokinetics

Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Cytokinetics’ lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil (formerly CK-1827452), is in clinical development for the potential treatment of heart failure. Amgen Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and related compounds, subject to Cytokinetics’ specified development and commercialization participation rights. Cytokinetics is independently developing CK-2017357, a skeletal muscle activator, as a potential treatment for diseases and conditions associated with aging, muscle wasting or neuromuscular dysfunction. CK-2017357 is currently the subject of a Phase IIa clinical trials program and has been granted orphan-drug designation by the U.S. Food and Drug Administration for the potential treatment of amyotrophic lateral sclerosis. Cytokinetics is also conducting non-clinical development of compounds that inhibit smooth muscle contractility and which may be useful as potential treatments for diseases and conditions associated with excessive smooth muscle contraction, such as bronchoconstriction associated with asthma and chronic pulmonary obstructive disease. In addition, prior Cytokinetics’ research generated three anti-cancer drug candidates that have progressed into clinical development: ispinesib, SB-743921 and GSK-923295. All of these drug candidates and potential drug candidates have arisen from Cytokinetics’ research activities and are directed towards the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. Additional information about Cytokinetics can be obtained at www.cytokinetics.com.

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the “Act”). Cytokinetics disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Act’s safe harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to planned presentations, and the properties and potential benefits of Cytokinetics’ drug candidates and potential drug candidates. Such statements are based on management’s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, potential difficulties or delays in the development, testing, regulatory approval and production of Cytokinetics’ drug candidates and potential drug candidates that could slow or prevent clinical development or product approval, including risks that current and past results of clinical trials or preclinical studies may not be indicative of future clinical trials results and that Cytokinetics’ drug candidates and potential drug candidates may have unexpected adverse side effects or inadequate therapeutic efficacy. For further information regarding these and other risks related to Cytokinetics’ business, investors should consult Cytokinetics’ filings with the Securities and Exchange Commission.

Contact:
Christopher S. Keenan
Director, Investor Relations
(650) 624-3000

EFI (EFII) Announces Preliminary First Quarter 2011 Revenue and Earnings Per Share Results

FOSTER CITY, Calif., April 11, 2011 (GLOBE NEWSWIRE) — Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, today announced preliminary unaudited results for the quarter ended March 31, 2011. Based on preliminary data, the Company expects to report revenues in the range of $139 million to $140 million and non-GAAP earnings per share (EPS) in the range of $0.27 to $0.28 per share, including a $0.03 benefit from currency. The Company had previously provided an outlook for the first quarter of 2011 of approximately $128 million in revenues, and non-GAAP EPS of $0.14 to $0.16 per share.

Guy Gecht, CEO of EFI, noted that the outstanding preliminary results reflect robust demand across the company’s three business segments, particularly in the Fiery product line. “We were very pleased with the approximately 25% year-over-year increase in revenues, driven by the growth and efficiencies our customers are achieving with EFI’s innovative technology. We continued to see strong customer loyalty for our Fiery digital print servers, along with accelerating demand globally for our software application products. At the same time, the strategic initiatives implemented to improve inkjet margins are showing solid results.”

Commenting on the tragic events in Japan, headquarters for several of EFI’s OEM partners, Gecht continued, “Our hearts go out to the Japanese people. With our long-standing strategic partnerships in Japan, we have developed many close friendships there. We have always had great admiration for the Japanese people’s strength and resilience and are confident in their ability to recover and rebuild. We will continue to monitor the recovery efforts for any potential impact on EFI’s operations or on our OEM partners.”

Q1 2011 Earnings Conference Call Information

EFI will report final, complete financial results on its first quarter 2011 earnings conference call scheduled for April 25, 2011 after the market closes. Investors will be able to access the conference call and slide presentation at the Investor Relations/Events & Presentations portion of EFI’s website at www.efi.com or by phone at (866) 613-9183 for domestic callers and (973) 409-9232 for international callers. The conference call ID is 59047043.

A replay of the webcast will also be available at the aforementioned website following the completion of the call.

About our Non-GAAP Net Income and Adjustments

To supplement our consolidated financial results prepared under generally accepted accounting principles, or GAAP, we use non-GAAP measures of net income (loss) and earnings per diluted share that are GAAP net income (loss) and GAAP earnings per diluted share adjusted to exclude certain recurring and non-recurring costs, expenses and gains.

We believe that the presentation of non-GAAP net income (loss) and non-GAAP earnings per diluted share provides important supplemental information to management and investors regarding non-cash expenses, significant recurring and non-recurring items that we believe are important to understanding our financial and business trends relating to our financial condition and results of operations. Non-GAAP net income (loss) and non-GAAP earnings per diluted share are among the primary indicators used by management as a basis for planning and forecasting future periods and by management and our board of directors to determine whether our operating performance has met specified targets and thresholds. Management uses non-GAAP net income (loss) and non-GAAP earnings per diluted share when evaluating operating performance because it believes that the exclusion of the items described below, for which the amounts and/or timing may vary significantly depending upon the Company’s activities and other factors, facilitates comparability of the Company’s operating performance from period to period. We have chosen to provide this information to investors so they can analyze our operating results in the same way that management does and use this information in their assessment of our business and the valuation of our Company.

We compute non-GAAP net income (loss) and non-GAAP earnings per diluted share by adjusting GAAP net income (loss) and GAAP earnings per diluted share to remove the impact of recurring amortization of acquisition-related intangibles, stock-based compensation expense, as well as restructuring related and non-recurring charges and gains and the tax effect of these adjustments. Such non-recurring charges and gains include end-of-life inventory purchase and related obsolescence, asset impairment charges, acquisition-related transaction costs and legal expenses, and costs to integrate such acquisitions into our business.

These non-GAAP measures are not in accordance with or an alternative for GAAP and may be materially different from other non-GAAP measures, including similarly titled non-GAAP measures, used by other companies. The presentation of this additional information should not be considered in isolation from, as a substitute for, or superior to, net income or earnings per diluted share prepared in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect certain items that may have a material impact upon our reported financial results. We expect to continue to incur expenses of a nature similar to the non-GAAP adjustments described above, and exclusion of these items from our non-GAAP net income (loss) and non-GAAP earnings per diluted share should not be construed as an inference that these costs are unusual, infrequent or non-recurring.

Safe Harbor for Forward Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements other than statements of historical fact including words such as “anticipate”, “believe”, “estimate”, “expect”, “consider” and “plan” and statements in the future tense are forward looking statements. The statements in this press release that could be deemed forward-looking statements include statements regarding EFI’s financial results for the quarter ended March 31, 2011 (including revenues and non-GAAP EPS), EFI’s positioning in the growth segments of digital printing, accelerating demand globally for EFI’s software application products, continuation of the execution of its strategy and momentum, and any statements or assumptions underlying any of the foregoing.

Forward-looking statements are subject to certain risks and uncertainties that could cause our actual future results to differ materially, or cause a material adverse impact on our results. Potential risks and uncertainties include, but are not necessarily limited to, inaccurate data or assumptions; unforeseen expenses; the difficulty of aligning expense levels with revenue changes; execution of actions to reduce our operational costs and ability to maintain effective cost control measures; unexpected declines in revenues or increases in expenses; management’s ability to forecast revenues, expenses and earnings, especially on a quarterly basis; the market prices of the Company’s common stock; the uncertainty regarding the amount and timing of future share repurchases by the Company and the origin of funds used for such repurchases; any world-wide financial and economic difficulties and downturns, including contraction in credit markets and adverse variations in foreign exchange rates, that could affect demand for our products, and increase the volatility of our profitability, as well as the risk of bank failures, insolvency or illiquidity of other financial institutions and other adverse conditions in financial markets that could cause a loss of our cash deposits and invested cash and cash equivalents; uncertainty to accurately predict the outcome of foreign tax audits and determine our tax provisions; uncertainty regarding our effective tax rate in the future that may be impacted by various factors, including but not limited to new U.S. tax legislative proposals; changes in, or the failure or inability to comply with U.S., foreign and local governmental regulations, including import/export regulations or duties; failure to retain key employees; product cancellation costs; a significant decline or delay in demand for our products by any of our important OEM partners; the unpredictability of development schedules and commercialization of the products manufactured and sold by our OEM partners; variations in growth rates or declines in the printing and imaging markets across various geographic regions; changes in historic customer order patterns, including changes in customer and channel inventory levels; changes in the mix of products sold leading to variations in operating results; the uncertainty of market acceptance of new product introductions; delays in product deliveries that cause quarterly revenues and income to fall significantly short of anticipated levels; competition and/or market factors, which may adversely affect margins; competition in each of our businesses, including competition from products internally developed by EFI’s customers; challenge of managing assets levels, including inventory and variations in inventory valuation; intense competition in the industrial and commercial digital inkjet market; the uncertainty of continued success in technological advances, including development and implementation of new processes and strategic products; the challenges of obtaining timely, efficient and quality product manufacturing and components supplying; litigation involving intellectual property rights or other related matters; our ability to successfully integrate acquired businesses, without operational disruption to our existing businesses; the potential that investments in new business strategies and initiatives could disrupt the Company’s ongoing businesses and may present risks not originally contemplated; the potential loss of sales, unexpected costs or adverse impact on relations with customers or suppliers as a result of acquisitions; differences between the financial results as filed with the SEC and the preliminary results included in our earnings or other press releases, among other things, due to the complexity in accounting rules; and any other risk factors that may be included from time to time in the Company’s SEC reports.

The statements in this press release are made as of the date of this press release. EFI undertakes no obligation to update information contained in this press release. For further information regarding risks and uncertainties associated with EFI’s businesses, please refer to the section entitled “Factors That Could Adversely Affect Performance” in the Company’s SEC filings, including, but not limited to, its annual report on Form 10-K and its quarterly reports on Form 10-Q, copies of which may be obtained by contacting EFI’s Investor Relations Department by phone at 650-357-3828 or by email at investor.relations@efi.com or EFI’s Investor Relations website at www.efi.com.

About EFI

EFI (www.EFI.com) is a world leader in customer focused digital printing innovation. EFI’s award-winning solutions, integrated from creation to print, deliver increased performance, cost savings and productivity. The company’s robust product portfolio includes Fiery digital color printer servers; VUTEK superwide digital inkjet printers, UV and solvent inks; Rasktek UV wide-format inkjet printers; Jetrion industrial inkjet printing systems; print production workflow and management information software; and corporate printing solutions.

The Electronics For Imaging, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7332

CONTACT: Investor Relations Contact:
         JoAnn Horne
         Market Street Partners
         415-445-3235

Level 3 (LVLT) to Acquire Global Crossing (GLBC)

Apr. 11, 2011 (Business Wire) — Level 3 Communications, Inc. (NASDAQ: LVLT) and Global Crossing Limited (NASDAQ: GLBC) today announced that they have entered into a definitive agreement under which Level 3 will acquire Global Crossing in a tax-free, stock-for-stock transaction. The combined company will operate a unique global services platform anchored by fiber optic networks on three continents, connected by extensive undersea facilities. The combined network will serve a worldwide customer set with owned network in more than 50 countries and connections to more than 70 countries. This transaction will create a company with pro forma combined 2010 revenues of $6.26 billion and pro forma combined 2010 Adjusted EBITDA of $1.27 billion before synergies and $1.57 billion after expected synergies.

Under the terms and subject to the conditions of the agreement, Global Crossing shareholders will receive 16 shares of Level 3 common stock for each share of Global Crossing common stock or preferred stock that is owned at closing. Based on Level 3’s closing stock price on April 8, 2011, the transaction is valued at $23.04 per Global Crossing common or preferred share, or approximately $3.0 billion, including the assumption of approximately $1.1 billion of net debt as of Dec. 31, 2010. Global Crossing has approximately 79 million basic and preferred shares outstanding and approximately 83 million shares outstanding on a fully diluted basis, giving effect to outstanding stock awards, but excluding performance-based stock grants.

The transaction will create a company with a unique capability to meet local, national and global customer requirements in a wide range of markets. By combining the strengths of each company, the new entity will offer enterprise, government, wholesale, content, and web-based customers a comprehensive portfolio of end-to-end data, video and voice solutions.

“This is a transformational combination that we believe will deliver significant value to the investors, customers and employees of both Level 3 and Global Crossing,” said Jim Crowe, chief executive officer of Level 3. “The complementary fit between the two companies’ networks, service portfolios and customers is compelling. By leveraging the respective strengths and extensive reach of both companies, we are creating a highly efficient and more extensive global platform that is well-positioned to meet the local and international needs of our customers.”

“This transaction will provide Global Crossing shareholders with an attractive premium and significant participation in the upside potential of a leading communications company with industry-leading scale and capabilities. The combined service capabilities, extensive network assets and talented employees of the two companies will create a stronger global communications competitor with compelling offerings in the marketplace,” said John Legere, chief executive officer of Global Crossing. “Each of our companies has a reputation for being nimble and flexible in meeting customers’ communications needs, and we expect that to continue – with the added benefit of offering customers significantly greater reach, products and services.”

“We’re looking forward to welcoming Singapore Technologies Telemedia, Global Crossing’s largest shareholder, as a significant investor,” said Crowe. “They are exceptionally sophisticated managers, with holdings in telecommunications and information companies in a number of countries. They know the technology and they know the industry. The breadth of their communications experience and their knowledge of international markets will be a great asset to us.”

“This strategic combination is an important milestone for both Global Crossing and Level 3, and a value-creating proposition for all stakeholders,” said Lee Theng Kiat, president and chief executive officer of Singapore Technologies Telemedia (ST Telemedia). “Going forward, we believe the combined strengths of the two companies will position it in a very favorable, competitive position to expand in the U.S. and compete globally.”

“We are committed to creating a high-performing combined business through a carefully managed integration plan executed by a select team from both companies,” said Jeff Storey, president and chief operating officer of Level 3. “We will begin integration planning immediately and bring an aggressive, disciplined approach to the process. After the closing, as we integrate the two operations and work to achieve our expected synergies, we will be dedicated to maintaining our focus on providing excellent customer service and growing our combined revenues.”

“The combination improves our balance sheet and credit profile immediately upon closing with further improvement as we achieve the benefits of integration. Additionally, the transaction accelerates the achievement of Level 3’s target leverage ratio of three to five times debt to Adjusted EBITDA,” said Sunit Patel, chief financial officer of Level 3. “Including the benefit of synergies and the cost of integration, we expect the transaction to be accretive to Level 3’s Free Cash Flow per share in 2013 and to give us the financial strength to capitalize on the many opportunities available in the global market.”

Benefits of the Transaction

Significant Synergy Opportunities

Through integration of the combined businesses, the transaction is expected to create substantial annualized Adjusted EBITDA synergies of approximately $300 million and annualized capital expenditure reduction of approximately $40 million. Level 3 expects to realize approximately two-thirds of the run rate Adjusted EBITDA synergies within 18 months of closing. The company estimates that the net present value of the potential synergies will be approximately $2.5 billion. Of the total expected synergies, approximately 39 percent are from network expense savings, approximately 49 percent from operating expense savings, and approximately 12 percent are from reductions in capital expenditures. The company expects to incur approximately $200 to $225 million of integration costs associated with this transaction. Approximately 55 percent of those costs are expected to be from operating expenses, and 45 percent are expected to be from capital expenditures to support integration activities.

Improved Financial Strength of Combined Business

Including the benefit of synergies and the cost of integration, the transaction is expected to be accretive to Level 3’s Free Cash Flow per share in 2013. As a result of potential revenue growth and synergies, over the longer term, Level 3 expects to have significant Free Cash Flow available for investment in high-return opportunities, including U.S. and international network expansions, and potential repurchase of the company’s securities.

Improvement to Level 3’s Credit Profile

The transaction is expected to improve Level 3’s credit profile as well as significantly strengthen the company’s balance sheet. On a pro forma basis and including the benefit of expected synergies, the ratio of net debt (including capital leases) to Adjusted EBITDA is expected to improve from 6.8x to 4.4x as of Dec. 31, 2010.

Expanded Global Footprint

Existing customers will benefit from expanded geographic reach and a combination of intercity networks and metro networks throughout North America, Latin America and Europe connected by extensive global subsea networks. The combined business will leverage Global Crossing’s long-term IRU’s on the PC1 and EAC cable systems, focusing on telecom operators based in Asia. The combined network will serve a worldwide customer set with owned network in more than 50 countries and reach to more than 70 countries.

Enhanced and Expanded Service Portfolio

The combined business will offer an extensive portfolio of transport, IP and data solutions, content delivery, data center, colocation and voice services, delivered globally. Global Crossing will bring important additions to Level 3’s service portfolio, including managed services, collaboration services and inter-continental virtual private networking capability. The combined service portfolio and distribution channels will allow Level 3 to better address the needs of enterprises, content providers, carriers and governments throughout North America, Latin America and Europe.

Expanded Enterprise Service Capabilities

Global Crossing’s enterprise service portfolio and proven sales expertise together with the improved cost structure and performance achievable by combining the extensive international, intercity and metro networks will enable opportunities for improved growth by giving enterprises better options to meet their local, national and international communications needs.

Committed Financing

Level 3 Financing, Inc., a wholly owned subsidiary of Level 3, has received committed financing for $1.75 billion in connection with this acquisition.

Voting Agreement and Stockholder Rights Agreement

In conjunction with this transaction, Level 3 has signed a Voting Agreement with ST Telemedia, the company which owns approximately 60 percent of Global Crossing’s stock, whereby ST Telemedia has agreed to vote its shares in favor of the transaction, subject to certain terms and conditions. Level 3 and ST Telemedia have also signed a Stockholder Rights Agreement, which becomes effective upon closing and which allows ST Telemedia to designate members to the Level 3 board of directors, proportionate to their stock ownership. In addition, the Stockholder Rights Agreement contains a standstill provision which imposes limitations on ST Telemedia’s ability to purchase or sell Level 3 common stock.

Approvals and Timing of Transaction

In addition to customary closing conditions, the transaction is subject to regulatory approvals relating to competition law, licensing, financing, and foreign ownership, including approvals by the U.S. Department of Justice, the U.S. Federal Communications Commission and other regulatory agencies in the U.S. and in countries where the companies do business. The transaction is also subject to the approval of the stockholders of each company. The transaction is expected to close before the end of this year.

Stockholder Rights Plan

Level 3 also announced separately today that it is adopting a Stockholder Rights Plan (Rights Plan). The Rights Plan is designed to protect Level 3’s federal Net Operating Losses (NOLs) from the effect of Internal Revenue Code Section 382, which can restrict the use of NOLs. The completion of the business combination with Global Crossing would move Level 3 significantly closer to the 50 percent ownership change outlined in Section 382, and increase the likelihood of a loss of Level 3’s valuable NOLs. The rights under the Rights Plan will expire under the circumstances described in the separate release announcing its adoption. In addition, Level 3’s board of directors intends, from time to time (and in particular upon the closing of the transaction), to consider whether maintaining the Rights Plan continues to be in the best interests of Level 3.

Advisors

BofA Merrill Lynch, Citi and Morgan Stanley acted as advisors to Level 3, and Rothschild provided a fairness opinion. Willkie Farr & Gallagher LLP acted as legal counsel to Level 3. Goldman, Sachs & Co. acted as financial advisor and Latham & Watkins acted as legal counsel to Global Crossing. Credit Suisse Securities (USA) LLC acted as financial advisor to ST Telemedia.

Conference Call and Webcast

Level 3 and Global Crossing will hold a joint investor and media conference call to discuss the announcement on April 11 at 9:00 a.m. EDT. To join the call, please dial 888-490-2763 or 719-325-2490, passcode: 9332976. A live webcast of the call can also be heard on Level 3’s website at http://lvlt.client.shareholder.com/events.cfm and at Global Crossing’s website at http://investors.globalcrossing.com. A replay of the call will run for 30 days from April 11, 2011 at 12:00 p.m. CDT until May 11, 2011 at 11:59 p.m. CDT. In order to access that call, please dial 888-203-1112 or 719-457-0820, replay passcode: 9332976.

About Level 3 Communications

Level 3 Communications, Inc. (NASDAQ: LVLT) is a leading international provider of fiber-based communications services. Enterprise, content, wholesale and government customers rely on Level 3 to deliver services with an industry-leading combination of scalability and value over an end-to-end fiber network. Level 3 offers a portfolio of metro and long-haul services, including transport, data, Internet, content delivery and voice. For more information, visit www.level3.com.

© Level 3 Communications, LLC. All Rights Reserved. Vyvx, Venuenet+, Level 3, Level 3 Communications and the Level 3 Communications Logo are either registered service marks or service marks of Level 3 Communications, LLC and/or one of its Affiliates in the United States and/or other countries. Level 3 services are provided by wholly owned subsidiaries of Level 3 Communications, Inc.

About Global Crossing

Global Crossing (NASDAQ: GLBC) is a leading global IP, Ethernet, data center and video solutions provider with the world’s first integrated global IP-based network. The company offers a full range of data, voice, collaboration, broadcast and media services delivered with superior customer service.

Global Crossing provides services to enterprises (including approximately 40 percent of the Fortune 500); government departments and agencies; and 700 carriers, mobile operators and ISPs. It delivers converged IP services to more than 700 cities in more than 70 countries, and has 17 world-class data centers in major business centers around the globe.

Please visit www.globalcrossing.com for more information about Global Crossing.

Forward Looking Statements About Global Crossing

This press release contains statements about expected future events and financial results that are forward looking and subject to risks and uncertainties that could cause the actual results to differ materially, including: the failure to occur of any condition to the closing of the acquisition of Global Crossing by Level 3, including the failure to obtain a required approval or the experiencing of a material adverse effect by either company; the failure to achieve expected synergies from the acquisition; Global Crossing’s history of substantial operating losses and the fact that, in the near term, funds from operations will not satisfy cash requirements; the availability of future borrowings in an amount sufficient to pay Global Crossing’s indebtedness and to fund its other liquidity needs; legal and contractual restrictions on the inter-company transfer of funds by Global Crossing’s subsidiaries; Global Crossing’s ability to continue to connect its network to incumbent carriers’ networks or maintain Internet peering arrangements on favorable terms; the consequences of any inadvertent violation of Global Crossing’s Network Security Agreement with the U.S. Government; increased competition and pricing pressures resulting from technology advances and regulatory changes; competitive disadvantages relative to competitors with superior resources; political, legal and other risks due to Global Crossing’s substantial international operations; risks associated with movements in foreign currency exchange rates; risks related to restrictions on the conversion of the Venezuelan bolivar into U.S. dollars and to the resultant buildup of a material excess bolivar cash balance, which is carried on Global Crossing’s books at the official exchange rate, attributing to the bolivar a value that is significantly greater than the value that would prevail on an open market; potential weaknesses in internal controls of acquired businesses, and difficulties in integrating internal controls of those businesses with Global Crossing’s own internal controls; exposure to contingent liabilities; and other risks referenced from time to time in Global Crossing’s filings with the Securities and Exchange Commission. Global Crossing undertakes no duty to update information contained in this press release or in other public disclosures at any time.

About Singapore Technologies Telemedia

Singapore Technologies Telemedia (ST Telemedia) invests in and manages an innovative group of information-communications companies across the globe. Its core competencies are in mobile communications and global IP services. Key companies in the ST Telemedia group include Global Crossing, a leading global IP and Ethernet solutions provider with the world’s first integrated global IP-based network; eircom, one of Ireland’s largest telecommunications operators; U Mobile Sdn Bhd, Malaysia’s 3G operator; TeleChoice, a leading regional diversified provider and enabler of innovative communication solutions; ST Teleport, Asia’s leading full-service satellite communications solution provider; VNPT Global, the leading company of VNPT in international business and Asia Mobile Holdings which holds interests in StarHub, Singapore’s fully-integrated info-communication company; and Shenington Investments

Important Information For Investors And Stockholders

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. The proposed transaction will be submitted to the stockholders of Level 3, Inc. (“Level 3”) and the stockholders of Global Crossing Limited (“Global Crossing”) for their consideration. Level 3 and Global Crossing will file a registration statement on Form S-4, a joint proxy statement/prospectus and other relevant documents concerning the proposed transaction with the SEC. Level 3 and Global Crossing will each provide the final joint proxy statement/prospectus to its respective stockholders. Investors and security holders are urged to read the registration statement and the joint proxy statement/prospectus and any other relevant documents filed with the SEC when they become available, as well as any amendments or supplements to those documents, because they will contain important information about Level 3, Global Crossing and the proposed transaction. Investors and security holders will be able to obtain a free copy of the registration statement and joint proxy statement/prospectus, as well as other filings containing information about Level 3 and Global Crossing free of charge at the SEC’s Web Site at http://www.sec.gov. In addition, the joint proxy statement/prospectus, the SEC filings that will be incorporated by reference in the joint proxy statement/prospectus and the other documents filed with the SEC by Level 3 may be obtained free of charge by directing such request to: Investor Relations, Level 3, Inc., 1025 Eldorado Boulevard, Broomfield, Colorado 80021 or from Level 3’s Investor Relations page on its corporate website at http://www.Level3.com and the joint proxy statement/prospectus, the SEC filings that will be incorporated by reference in the joint proxy statement/prospectus and the other documents filed with the SEC by Global Crossing be obtained free of charge by directing such request to: Global Crossing by telephone at (800) 836-0342 or by submitting a request by e-mail to glbc@globalcrossing.com or a written request to the Secretary, Wessex House, 45 Reid Street, Hamilton HM12 Bermuda or from Global Crossing’s Investor Relations page on its corporate website at http://www.globalcrossing.com.

Level 3, Global Crossing and their respective directors, executive officers, and certain other members of management and employees may be deemed to be participants in the solicitation of proxies in favor of the proposed transactions from the stockholders of Level 3 and from the stockholders of Global Crossing, respectively. Information about the directors and executive officers of Level 3 is set forth in the proxy statement on Schedule 14A for Level 3’s 2011 Annual Meeting of Stockholders, which was filed with the SEC on April 4, 2011 and information about the directors and executive officers of Global Crossing is set forth in the proxy statement for Global Crossing’s 2010 Annual Meeting of Stockholders, which was filed with the SEC on May 19, 2010. Additional information regarding participants in the proxy solicitation may be obtained by reading the joint proxy statement/prospectus regarding the proposed transaction when it becomes available.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, (i) statements about the benefits of the acquisition of Global Crossing by Level 3, including financial and operating results and synergy benefits that may be realized from the acquisition and the timeframe for realizing those benefits; Level 3’s and Global Crossing’s plans, objectives, expectations and intentions and other statements contained in this communication that are not historical facts; and (ii) other statements identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” or words of similar meaning.

These forward-looking statements are based upon management’s current beliefs or expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies and third-party approvals, many of which are beyond our control. The following factors, among others, could cause actual results to differ materially from those expressed or implied in the forward-looking statements: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Agreement and Plan of Amalgamation among Level 3, Global Crossing and Global Crossing Amalgamation Sub, Ltd. (the “Amalgamation Agreement”); (2) the inability to complete the transactions contemplated by the Amalgamation Agreement due to the failure to obtain the required stockholder approvals; (3) the inability to satisfy the other conditions specified in the Amalgamation Agreement, including without limitation the receipt of necessary governmental or regulatory approvals required to complete the transactions contemplated by the Amalgamation Agreement; (4) the inability to successfully integrate the businesses of Level 3 and Global Crossing or to integrate the businesses within the anticipated timeframe; (5) the risk that the proposed transactions disrupt current plans and operations, increase operating costs and the potential difficulties in customer loss and employee retention as a result of the announcement and consummation of such transactions; (6) the ability to recognize the anticipated benefits of the combination of Level 3 and Global Crossing, including the realization of revenue and cost synergy benefits; and to recognize such benefits within the anticipated timeframe; (7) the outcome of any legal proceedings that may be instituted against Level 3, Global Crossing or others following announcement of the Amalgamation Agreement and transactions contemplated therein; and (8) the possibility that Level 3 or Global Crossing may be adversely affected by other economic, business, and/or competitive factors.

Other important factors that may affect Level 3’s and the combined business’ results of operations and financial condition include, but are not limited to: the current uncertainty in the global financial markets and the global economy; a discontinuation of the development and expansion of the Internet as a communications medium and marketplace for the distribution and consumption of data and video; disruptions in the financial markets that could affect Level 3’s ability to obtain additional financing, and the company’s ability to: increase and maintain the volume of traffic on its network; develop effective business support systems; manage system and network failures or disruptions; develop new services that meet customer demands and generate acceptable margins; defend intellectual property and proprietary rights; adapt to rapid technological changes that lead to further competition; attract and retain qualified management and other personnel; successfully integrate acquisitions; and meet all of the terms and conditions of debt obligations.

Additional information concerning these and other important factors can be found within Level 3’s and Global Crossing’s respective filings with the SEC, which discuss the foregoing risks as well as other important risk factors that could contribute to such differences or otherwise affect our business, results of operations and financial condition. Statements in this communication should be evaluated in light of these important factors. The forward-looking statements in this communication speak only as of the date they are made. Except for the ongoing obligations of Level 3 and Global Crossing to disclose material information under the federal securities laws, neither Level 3 nor Global Crossing undertakes any obligation to, and expressly disclaim any such obligation to, update or alter any forward-looking statement to reflect new information, circumstances or events that occur after the date such forward-looking statement is made unless required by law.

Non-GAAP Metrics

Pursuant to Regulation G, the company is hereby providing a reconciliation of non-GAAP financial metrics to the most directly comparable GAAP measure.

The following describes and reconciles those financial measures as reported under accounting principles generally accepted in the United States (GAAP) with those financial measures as adjusted by the items detailed below and presented in the accompanying news release. These calculations are not prepared in accordance with GAAP and should not be viewed as alternatives to GAAP. In keeping with its historical financial reporting practices, the company believes that the supplemental presentation of these calculations provides meaningful non-GAAP financial measures to help investors understand and compare business trends among different reporting periods on a consistent basis, independently of regularly reported non-cash charges and infrequent or unusual events.

Combined Total Revenue is defined as combined total revenue from the Consolidated Statements of Operations as filed in each company’s Annual Report on Form 10-K for the year ended December 31, 2010.

Communications Revenue is defined as communications revenue from Level 3 Communications’ Consolidated Statements of Operations.

Adjusted EBITDA is defined as net income (loss) from the Consolidated Statements of Operations before income taxes, total other income (expense), non-cash impairment charges, depreciation and amortization and non-cash stock compensation expense.

Adjusted EBITDA plus Estimated Synergies is defined as Adjusted EBITDA plus the estimated synergies resulting from the combination.

Total Debt, including Capital Leases is defined as the current and long-term portions of debt and obligations under capital leases as reported in the Consolidated Balance Sheets filed in each company’s Annual Report on Form 10-K for the year ended December 31, 2010.

Cash and Cash Equivalents is defined as the total cash and cash equivalents reported as a component of current assets in the Consolidated Balance Sheets as filed in each company’s Annual Report on Form 10-K for the year ended December 31, 2010.

Debt to Adjusted EBITDA Ratio is defined as Total Debt, including Capital Leases divided by Adjusted EBITDA.

Net Debt to Adjusted EBITDA Ratio is defined as Total Debt, including Capital Leases reduced by the Cash and Cash Equivalents, divided by Adjusted EBITDA.

Management believes that Adjusted EBITDA and Adjusted EBITDA plus Estimated Synergies are relevant and useful metrics to provide to investors, as they are an important part of the company’s internal reporting and are key measures used by Management to evaluate profitability and operating performance of the company and to make resource allocation decisions. Management believes such measures are especially important in a capital-intensive industry such as telecommunications. Management also uses Adjusted EBITDA and Adjusted EBITDA plus Estimated Synergies to compare the company’s performance to that of its competitors and to eliminate certain non-cash and non-operating items in order to consistently measure from period to period its ability to fund capital expenditures, fund growth, service debt and determine bonuses. Adjusted EBITDA excludes non-cash impairment charges and non-cash stock compensation expense because of the non-cash nature of these items. Adjusted EBITDA also excludes interest income, interest expense and income taxes because these items are associated with the company’s capitalization and tax structures. Adjusted EBITDA also excludes depreciation and amortization expense because these non-cash expenses reflect the impact of capital investments which management believes should be evaluated through free cash flow. Adjusted EBITDA excludes the gain (or loss) on extinguishment of debt and other, net because these items are not related to the primary operations of the company.

There are limitations to using non-GAAP financial measures, including the difficulty associated with comparing companies that use similar performance measures whose calculations may differ from the company’s calculations. Additionally, this financial measure does not include certain significant items such as interest income, interest expense, income taxes, depreciation and amortization, non-cash impairment charges, non-cash stock compensation expense, the gain (or loss) on extinguishment of debt and net other income (expense). Adjusted EBITDA and Adjusted EBITDA plus Estimated Synergies should not be considered a substitute for other measures of financial performance reported in accordance with GAAP.

Free Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures as disclosed in the Consolidated Statements of Cash Flows in each company’s Annual Report on Form 10-K for the year ended December 31, 2010. Management believes that Free Cash Flow and Free Cash Flow plus Estimated Synergies are relevant metrics to provide to investors, as it is an indicator of the company’s ability to generate cash to service its debt. Free Cash Flow excludes cash used for acquisitions and principal repayments.

There are material limitations to using Free Cash Flow to measure the company against some of its competitors as Level 3 does not currently pay a significant amount of income taxes due to net operating losses, and therefore, generates higher cash flow than a comparable business that does pay income taxes. Additionally, this financial measure is subject to variability quarter over quarter as a result of the timing of payments related to accounts receivable and accounts payable and capital expenditures. This financial measure should not be used as a substitute for net change in cash and cash equivalents on the Consolidated Statements of Cash Flows.

Level 3 Media Contact:

Josh Howell, + 1 720-888-3912

Media.Relations@level3.com

or

Level 3 Investor Contact:

Mark Stoutenberg, + 1 720-888-1662

Investor.Relations@level3.com

or

Global Crossing Media Contact:

Michael Schneider, + 1 973-937-0146

Michael.Schneider@globalcrossing.com

or

Global Crossing Investor Contact:

Mark Gottlieb, + 1 800-836-0342

glbc@globalcrossing.com

Flowers Foods (FLO) and Tasty Baking Company (TSTY) Announce All Cash Merger Agreement

China GengSheng Minerals (CHGS) Acquires Minority Interest in Yili Yiqiang Silicon Company

GONGYI, China, April 7, 2011 /PRNewswire-Asia-FirstCall/ — China GengSheng Minerals, Inc. (AMEX:CHGS), a leading China-based high-tech industrial materials manufacturer producing heat resistant, energy efficient materials for a variety of industrial applications, today announced that it has signed an agreement to acquire 24.5% ownership in the Yili Yiqiang Silicon Company (Yili Yiqiang) for RMB 15 million (approximately US$2.3 million). Yili Yiqiang is a manufacturer of green silicon carbide (“SiC”), which is the primary material used in the production of GengSheng’s fine precision abrasive products.

The Company funded this investment through a combination of cash from operations and domestic commercial bank loans. It is expected to close by April 10th, 2011.

“Acquiring a minority stake in Yili Yiqiang enhances our emerging fine precision abrasives products and furthers our strategy to increase our sales and margins in this segments of our business,” said Mr. Shunqing Zhang, China GengSheng’s Chairman and Chief Executive Officer, “With raw material costs high and continuing to rise as a result of tight capacity, our ability to improve the sourcing of high-quality, cost-effective green SiC was crucial to our success in this market. In addition to cost savings, we believe this investment will allow us greater control over the raw material production process, further improving the quality of the green SiC that Yili Yiqiang manufactures.”

Yili Yiqiang, located in Yili, Xinjiang Province in China, one of the region’s leading producers of high-quality green SiC, with average purity of 98.8%. Yili Yiqiang has green SiC reserves of approximately six million metric tons, and current annual production capacity of approximately 16,000 metric tons. Yili Yiqiang expects 2011 revenue of approximately $24 million, based on current production capacity and an average green SiC price of $1,500 per metric ton.

Through this investment, Yili Yiqiang has granted GengSheng right of first refusal on its production output, ensuring consistent, low-cost supply of the principal raw material used in the manufacture of fine precision abrasives.

Mr. Zhang continued, “As one of the safest clean energy technologies, the solar industry is experiencing tremendous growth, which is creating a sizeable market opportunity for fine precision abrasive products. Having launched this product line in third quarter of 2010, we believe that we can grow sales and expand margins by improving overall manufacturing efficiency and continued effective product marketing. With these key objectives in mind and our minority position in Yili Yigiang, we expect that our fine precision abrasives products will contribute to profitability and top-line growth in 2011.”

About China GengSheng Minerals, Inc.

China GengSheng Minerals, Inc. (“GengSheng”) develops, manufactures and markets a broad range of high-tech industrial material products, including monolithic refractories, industrial ceramics, fracture proppants and fine precision abrasives. A market leader offering customized solutions, GengSheng sells its products primarily to the iron and steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment, while reducing their consumption of energy. Founded in 1986 and based in China’s Henan province, GengSheng currently has over 200 customers in the iron, steel, oil, glass, cement, aluminum and chemical businesses located in China and other countries. GengSheng conducts business through GengSheng International Corporation, a British Virgin Islands company, and its Chinese subsidiaries, which are Henan GengSheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd., Henan GengSheng Micronized Powder Materials Co., Ltd, Guizhou SouthEast Prefecture Co., Ltd., GengSheng New Materials Co., Ltd, and Henan GengSheng High Temperature Materials Co., Ltd.

For more information about the Company, please visit http://www.gengsheng.com .

To be added to the Company’s email distribution for future press releases, please send your request to gengsheng@tpg-ir.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements“ relating to the business of China GengSheng Minerals, Inc., and its subsidiary companies. All statements other than statements of historical fact included herein are “forward-looking statements“ within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company‘s ability to meet its projected output for the term of the supply contract; the general ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,“ “expects“ or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company‘s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company‘s periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

China Sky One Medical (CSKI) Obtains Production Licenses for Thirteen New Medical Products

HARBIN, China, April 7, 2011 /PRNewswire-Asia-FirstCall/ — China Sky One Medical, Inc. (“China Sky One Medical” or “the Company”) (NASDAQ: CSKI), a leading fully integrated pharmaceutical company in the People’s Republic of China (“PRC”), today announced that the Company, jointly with Heilongjiang Traditional Chinese Medical University (“HTCMU”), has obtained production licenses for thirteen new medical products from the Heilongjiang Food and Drug Administration (“Heilongjiang FDA”) in China. These thirteen products include:

China Sky One is preparing for trial production and searching for the best production process for these thirteen products, which the Company expects to introduce to the market as soon as the fourth quarter of 2011.

“We are pleased to obtain production licenses for these exciting new products, which as a group we believe will contribute materially to China Sky One’s revenue and net income in 2012,” commented Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. “As these mostly external-use medical products dovetail well with our existing production facilities and sales network, we expect to manufacture and sell them efficiently without much extra effort. Going forward, we plan to strengthen our partnership with research institutions such as HTCMU, leveraging their R&D capabilities to enrich our product portfolio and improve the Company’s profitability.”

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as “believe,“ “expect,“ “may,“ “will,“ “should,“ “project,“ “plan,“ “seek,“ “intend,“ or “anticipate“ or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company‘s brand recognition and product quality. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People‘s Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, the potential of introduced or undetected flaws and defects in products, consumer acceptance of new products to be launched, including the thirteen new medical products for which the Company received production license approval from Heilongjiang FDA, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

OCZ Technology (OCZ) Now Shipping Vertex 3 Solid State Drive Series

SAN JOSE, Calif., April 7, 2011 (GLOBE NEWSWIRE) — OCZ Technology Group, Inc. (Nasdaq:OCZ), a leading provider of high-performance solid-state drives (SSDs) for computing devices and systems, today announced the availability of the Vertex 3 SATA III SSD Series through the Company’s extensive reseller network. Market availability will vary by region with wider overall availability continuing to ramp in the coming weeks.

“The Vertex 3 series with the SandForce SF-2200 SSD processor has been eagerly anticipated in the marketplace,” said Ryan Petersen, CEO of OCZ Technology Group. “Our partnership with SandForce has again facilitated the introduction of a solution that sets the benchmark for industry leading performance and reliability.”

Recently showcased at the CeBIT tradeshow along with the Vertex 3 Pro, the Vertex 3 is the first available solution to feature the new SandForce SF-2200 SSD processor which harnesses the 6Gbps speed of the SATA III interface to deliver double the performance of the previous generation. The new Vertex 3 raises the bar with up to 550MB/s of bandwidth and up to 60,000 IOPS (4k random write), and is now available in 120GB, 240GB, and 480GB capacities. The enterprise-class Vertex 3 Pro series is expected to begin shipping mid-Q2.

About OCZ Technology Group, Inc.

Founded in 2002, San Jose, CA-based OCZ Technology Group, Inc. (OCZ), is a leader in the design, manufacturing, and distribution of high performance and reliable Solid-State Drives (SSDs) and premium computer components. OCZ has built on its expertise in high-speed memory to become a leader in the SSD market, a technology that competes with traditional rotating magnetic hard disk drives (HDDs). SSDs are faster, more reliable, generate less heat and use significantly less power than the HDDs used in the majority of computers today. In addition to SSD technology, OCZ also offers high performance components for computing devices and systems, including enterprise-class power management products as well as leading-edge computer gaming solutions. For more information, please visit: www.ocztechnology.com.

The OCZ Technology Group, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7439

Forward-Looking Statements

Certain statements in this press release relate to future events and expectations, including the belief that the transaction will close within 30 days, the expectation that it will accelerate our storage technology innovation, that it will significantly enhance our ability to capitalize on worldwide demand for solid state disk drives, that it will increase customer and stockholder value, that it will expand our reach into embedded markets, that the transaction will become accretive to its earnings per share toward the end of this fiscal year on a non-GAAP basis, excluding acquisition-related expenses, restructuring charges and amortization of intangibles, and, as such constitute forward-looking statements involving known and unknown factors that may cause actual results of OCZ to be different from those expressed or implied in the forward-looking statements. In this context, words such as “will,” “would,” “expect,” “anticipate,” “should” or other similar words and phrases often identify forward-looking statements made on behalf of OCZ. It is important to note that actual results of OCZ may differ materially from those described or implied in such forward-looking statements based on a number of factors and uncertainties, including, but not limited to, the anticipated timing of filings and approvals relating to the acquisition of Indilinx; the satisfaction of other closing conditions; the expected timing of the completion of the acquisition; the ability to successfully integrate the products, services and employees of Indilinx; potential negative impacts from the recent earthquake in Japan; the ability to successfully develop and market new products and services; our ability to maintain other supplier and customer relationships; market acceptance of our products and our ability to continually develop enhanced products; adverse changes both in the general macro-economic environment as well as in the industries we serve, including computer manufacturing, traditional and online retailers, information storage, internet search and content providers and computer system integrators; our ability to efficiently manage material and inventory, including integrated circuit chip costs and freight costs; and our ability to generate cash from operations, secure external funding for our operations and manage our liquidity needs. Other general economic, business and financing conditions and factors are described in more detail in “Item 1A — Risk Factors” in Part I in OCZ’s Annual Report on Form 10-K filed with the SEC on May 20, 2010 and statements made in other subsequent filings. The filings are available both at www.sec.gov as well as via OCZ’s website at www.ocztechnology.com. OCZ does not undertake to update its forward-looking statements.

CONTACT:  OCZ Technology Group, Inc.
          Bonnie Mott, Investor Relations Manager
          408-440-3428
          bmott@ocztechnology.com

T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial

Mad Catz Interactive Inc. (MCZ)

Mad Catz Interactive Inc. primarily develops and markets innovative products for the interactive entertainment industry, the majority of which include markets accessories for videogame systems and PCs under its Mad Catz (casual gaming), Saitek (simulation), Cyborg (pro gaming), Eclipse (home and office) and Tritton (gaming audio) brands.

The Company also operates e-commerce and content websites for videogame and PC products under its GameShark brand, develops, manufactures and markets proprietary earphones under its AirDrives brand, and publishes and distributes video/PC games. Mad Catz’s products are distributed through most of the leading retailers offering interactive entertainment products and has offices in North America, Europe and Asia.

For the last quarter of 2010, the Company reported $93.0 million in net sales, 90.6% higher than the previous year and an all-time record. Mad Catx ended the quarter with $9.9 million of cash, $51.2 million of accounts receivable, $32.5 million of inventories and accounts payable of $55.3 million. According to CEO Darren Richardson, significant improvements to the balance sheet are expected over the next year.

A leader in a dynamic, fast-growing industry that has solid prospects for continuing growth, Mad Catz is currently focused on expanding its product breadth, distribution network and licensing portfolio. The company has growing market share, considerable operating leverage, working capital to fund future growth, and a knowledgeable and skilled management team.

Uroplasty Announces Expanded Insurance Coverage of Posterior Tibial Nerve Stimulation (PTNS)

MINNEAPOLIS, April 5, 2011 /PRNewswire/ — Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms. Effective April 1, 2011, UnitedHealthcare, a nationwide private insurer, and, effective March 17, 2011, Excellus BlueCross BlueShield (BCBS), a regional insurer in upstate New York, initiated coverage of PTNS.

UnitedHealthcare is the largest single health insurer in the United States covering approximately 33 million lives nationwide. UnitedHealthcare affiliates include AmeriChoice, Great Lakes Health Plan, Health Net of CT, Oxford Health Plans, PacifiCare, Sierra Health and Life, among many others. Excellus BCBS provides health insurance to approximately 1.6 million individuals across upstate New York.

Uroplasty also announced that CIGNA Government Services, the new Medicare carrier for Kentucky effective May 1, 2011, will cover PTNS treatments effective that date. This adds approximately 750,000 lives to the approximately 1.7 million CIGNA covers in Idaho and North Carolina. The addition of Kentucky extends PTNS coverage to approximately 30 million Medicare beneficiaries in 30 states.

“The expansion of PTNS coverage by these leading health insurance providers represents significant progress for our Company,” said David Kaysen, President and CEO of Uroplasty, Inc. “We believe this expanded coverage reflects the strong clinical data that support the efficacy and safety of Urgent PC for the treatment of OAB and associated symptoms. Along with key opinion leaders from the urology field, we continue to meet with other insurers to present the benefits of Urgent PC and anticipate that adoption and coverage of PTNS will continue to grow.”

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent PC Neuromodulation System, the only FDA-cleared system that delivers posterior tibial nerve stimulation for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

Forward-Looking Information

This press release contains forward-looking statements that reflect our best estimates regarding future events and financial performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our anticipated results. We discuss in detail the factors that may affect the achievement of our forward-looking statements in our Annual Report on Form 10-K filed with the SEC. In particular, we cannot be certain that the rate of reimbursement for PTNS treatments will be adequate to justify the cost of our product, that other Medicare carriers or private payers will provide coverage for this treatment, or that any of the other risks identified in our 10-K will not adversely affect our expectations as described in these forward-looking statements.

VirnetX (VHC) Awarded New Patent, Included in Current Infringement Lawsuits

Good Times Restaurants Inc. (GTIM) Reports 2nd Quarter Sales Results and New Ad Agency

Apr. 5, 2011 (Business Wire) — Good Times Restaurants Inc. (Nasdaq: GTIM) today announced its eighth consecutive month of same store sales increases with March sales increasing 8.6% from the prior year and that its same store sales for the second quarter of fiscal 2011 increased 5.7%. Year to date for the first six months of the fiscal year same store sales have increased 9.6%.

Commenting on the sales improvement, President & CEO, Boyd Hoback said, “We continue to see results both in an increase in our average check and stable transactions from focusing on our core equity in product quality, including the 2^nd quarter promotion of our Fresh Grilled, Honey Cured Bacon products. While we continue to benefit from mild weather this year, it is encouraging that we are achieving sales growth with little to no traditional media support and lower advertising costs. We rolled out Cheese Fries and Loaded Fries in March to leverage our cooked-to-order Fresh Cut Fries and Wild Fries and plan to begin some media support through the spring and summer months with a pipeline of unique product offerings.”

The Company also reported that it has engaged Sukle Advertising & Design in Denver as its agency of record for fiscal 2011 and is working on a refreshed design platform that will come to life in building graphics, packaging, point-of-purchase materials, menu boards and employee uniforms. Hoback added, “We are pleased to be working with Mike Sukle and his team as we refresh and rejuvenate Good Times’ image across all customer touchpoints. Sukle has a reputation for executing big-picture ideas with fresh thinking and innovative designs. We hope to have new menu boards, refreshed building exteriors and new packaging design in place in 2011 to augment a heightened focus on store-level communications and elevating our customers’ experience. Continued compound same store sales growth is our top priority as we work through the uncertain commodity cost environment and continue to explore alternatives for new restaurant growth.”

Sukle Advertising & Design is a Denver-based agency that has been crafting globally recognized, compelling and memorable ideas that create results for clients, such as Noodles & Company, Deep Rock Water, Gates Rubber Corp., Denver Water and many others in a variety of industries.

Good Times is a regional chain of quick service restaurants located primarily in Colorado providing a menu of high-quality all-natural hamburgers, 100% breast of chicken sandwiches, fresh frozen custard, fresh squeezed lemonades and other unique offerings. Good Times currently operates and franchises 49 restaurants.

This press release contains forward looking statements within the meaning of federal securities laws. The words “intend,” “may,” “believe,” “will,” “should,” “anticipate,” “expect,” “seek” and similar expressions are intended to identify forward looking statements. These statements involve known and unknown risks, which may cause Good Times’ actual results to differ materially from results expressed or implied by the forward looking statements. These risks include such factors as the uncertain nature of current restaurant development plans and the ability to implement those plans, delays in developing and opening new restaurants because of weather, local permitting or other reasons, increased competition, cost increases or shortages in raw food products, and other matters discussed under the “Risk Factors” section of Good Times’ Annual Report on Form 10-K for the fiscal year ended September 30, 2009 filed with the SEC. Although Good Times may from time to time voluntarily update its forward looking statements, it disclaims any commitment to do so except as required by securities laws.

Good Times Restaurants Inc.

Investor Relations Contacts:

Boyd E. Hoback, 303-384-1411

President and CEO

or

Christi Pennington, 303-384-1440

Executive Assistant

Merck to Acquire Inspire Pharmaceuticals, Inc. (ISPH)

Apr. 5, 2011 (Business Wire) — Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today announced that they have entered into a definitive agreement under which Merck will acquire Inspire, a specialty pharmaceutical company focused on developing and commercializing ophthalmic products.

Under the terms of the agreement, Merck, through a subsidiary, will commence a tender offer for all outstanding common stock of Inspire at a price of $5.00 per share in cash, a 26 percent premium to the closing price of Inspire’s common stock on April 4, 2011. The transaction has a total cash value of approximately $430 million. The transaction has been unanimously approved by the boards of directors of both companies and Inspire’s board recommended that the company’s shareholders tender their shares pursuant to the tender offer. In addition, Warburg Pincus Private Equity IX, L.P., which owns approximately 28 percent of the outstanding shares of Inspire, has agreed to tender all of its shares into the offer.

“Merck continues to build upon its long-term commitment to improving therapeutic options for the treatment of eye diseases,” said Beverly Lybrand, senior vice president and general manager, neuroscience and ophthalmology, Merck. “This acquisition combines the talented commercialization organization at Inspire with the excellent team already in place at Merck thereby strengthening our ophthalmology business and positioning us for future growth with an expanded portfolio. This deal helps address the needs of patients and customers in ophthalmology and creates value for both companies.”

In March, 2011, Merck announced that the New Drug Application (NDA) for SAFLUTAN^® (tafluprost), an investigational preservative-free prostaglandin analogue ophthalmic solution, had been accepted for standard review by the U.S. Food and Drug Administration (FDA). SAFLUTAN is the proposed trade name for tafluprost in the United States.

“As one of the world’s leading healthcare companies, Merck is the ideal partner to enhance the long-term potential of Inspire’s portfolio of ophthalmic assets. We are delighted that Merck recognized the strength of an integrated platform leveraging the growing AZASITE^® (azithromycin ophthalmic solution) 1% product opportunity and the strong relationships within the ophthalmic community cultivated by our high quality, specialty eye care sales force in the U.S.,” said Adrian Adams, president and CEO of Inspire. “Based upon an extensive analysis of various strategic options, as I have outlined since we announced the results of the TIGER-2 Phase 3 clinical trial, we believe this combination provides a compelling and timely opportunity for our shareholders to realize the value of their investment in Inspire.”

The closing of the tender offer will be subject to certain conditions, including the tender of a number of Inspire shares that, together with shares owned by Merck, represent at least a majority of the total number of Inspire’s outstanding shares (assuming the exercise of all options and vesting of restricted stock units), the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. Upon the completion of the tender offer, Merck will acquire all remaining shares through a second-step merger.

About AZASITE

Indication: AZASITE^® (azithromycin ophthalmic solution) 1% is indicated for the treatment of bacterial conjunctivitis in patients one year and older caused by the following organisms: CDC coryneform group G*, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group, and Streptococcus pneumoniae.

Important Selected Safety Information: AZASITE should not be administered systemically, injected subconjunctivally, or introduced directly into the anterior chamber of the eye. In patients receiving systemically administered azithromycin, serious allergic reactions, including angioedema, anaphylaxis, Stevens Johnson Syndrome and toxic epidermal necrolysis have been reported rarely. Although rare, fatalities have been reported.

As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Patients should not wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.

Azithromycin should be used during pregnancy only if clearly needed.

The most frequently reported ocular adverse event reported in clinical trials was eye irritation which occurred in 1-2 percent of patients. Other adverse events reported in <1 percent of patients included: ocular reactions (blurred vision, burning, stinging and irritation upon instillation, contact dermatitis, corneal erosion, dry eye, eye pain, itching, ocular discharge, punctate keratitis, visual acuity reduction) and non-ocular reactions (dysgeusia, facial swelling, hives, nasal congestion, periocular swelling, rash, sinusitis, urticaria).

*Efficacy for this organism was studied in fewer than 10 infections.

About Inspire

Inspire is a specialty pharmaceutical company focused on developing and commercializing ophthalmic products. Inspire’s specialty eye care sales force generates revenue from the promotion of AZASITE^® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis. Inspire receives royalties based on net sales of RESTASIS^® (cyclosporine ophthalmic emulsion) 0.05% and DIQUAS^™ Ophthalmic Solution 3% (diquafosol tetrasodium) in Japan. For more information, visit www.inspirepharm.com.

About Merck

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.

Inspire Forward-Looking Statement

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The forward-looking statements in this news release relating to management’s expectations and beliefs are based on preliminary information and management assumptions. Specifically, no assurances can be made that the holders of at least a majority of the outstanding shares of Inspire’s common stock will tender their shares pursuant to the tender offer or that the other conditions of the tender offer will be met. Furthermore, no assurances can be made with respect to the strength of Inspire’s integrated platform growing the AZASITE product opportunity.

Such forward-looking statements are subject to a wide range of risks and uncertainties that could cause results to differ in material respects, including those relating to product development, revenue, expense and earnings expectations, the introduction of a generic form of epinastine, intellectual property rights, competitive products, results and timing of clinical trials, success of marketing efforts, the need for additional research and testing, delays in manufacturing, funding, and the timing and content of decisions made by regulatory authorities, including the U.S. Food and Drug Administration. Further information regarding factors that could affect Inspire’s results is included in Inspire’s filings with the SEC. Inspire undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof.

Merck Forward Looking Statement

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company’s plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period; the impact of pharmaceutical industry regulation and health care legislation; the risk that the businesses will not be integrated successfully; disruption from the merger making it more difficult to maintain business and operational relationships; Merck’s ability to accurately predict future market conditions; dependence on the effectiveness of Merck’s patents and other protections for innovative products; the risk of new and changing regulation and health policies in the United States and internationally and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2010 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Important Information about the Tender Offer

The description contained in this press release is neither an offer to purchase nor a solicitation of an offer to sell securities. The planned tender offer described in this press release has not commenced. At the time the planned tender offer is commenced, a tender offer statement on Schedule TO will be filed by Merck with the SEC, and Inspire will file a solicitation/recommendation statement on Schedule 14D-9, with respect to the planned tender offer. The tender offer statement (including an offer to purchase, a related letter of transmittal and other tender offer documents) and the solicitation/recommendation statement will contain important information that should be re ad carefully before making any decision to tender securities in the planned tender offer. Those materials will be made available to Inspire’s stockholders at no expense to them. In addition, all of those materials (and all other tender offer documents filed with the SEC) will be made available at no charge on the SEC’s website at www.sec.gov.

SAFLUTAN^® is a registered trademark of Merck, Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All other brands are trademarks of their respective owners and are not trademarks of Merck & Co., Inc., Whitehouse Station, N.J., USA

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6672219&lang=en

Merck

Media:

Ian McConnell

908-423-3046

Investor:

Carol Ferguson or Joe Romanelli

908-423-5088

or

Inspire Pharmaceuticals, Inc.

Media:

Cara Amoroso

919-287-1266

or

Investor:

Jenny Kobin

919-287-1219

ZBB Energy (ZBB) to Provide Energy Storage for Army’s Micro-Grid Project

OncoSec Medical (ONCS) Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals (INO)

Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial

SmartHeat Inc. Announces Record Full Year 2010 Financial Results – 52% Revenue Growth, 47% Net Income Growth

NEW YORK, March 15, 2011 /PRNewswire-Asia/ — SmartHeat Inc. (Nasdaq: HEAT; website: www.smartheatinc.com), a market leader in China’s clean technology, energy savings industry, today announced record financial results for the year ended December 31, 2010. SmartHeat management is scheduled to host an investor conference call at 8:30 a.m. EDT on March 15, 2011.

Financial Highlights:

• Revenues of $125.41 million, up 51.89% from 2009
• Operating income of $26.69 million, up 46.85% from 2009
• Net income of $22.69 million, up 46.99% from 2009

Business Highlights:

• Meets or exceeds guidance for 2010
• Commences acquisition strategy with German heat pump manufacturer and designer GWP in the first quarter of 2011
• Continues with market expansion in Western China and nuclear industry

Revenues

In 2010, total sales increased 51.89% to $125.41 million compared to $82.56 million in 2009.

In the fourth quarter of 2010, total sales increased 60.61% to $41.79 million compared to $26.02 million in 4Q09. All three of the Company’s product lines contributed to higher sales in 2010 and were a result of China’s energy-saving policies, continued growth in energy-saving industry, and our successful market expansion.

The breakdown of revenues for 2010 was $55.44 million from PHE units and $60.22 million from heat exchangers, with sales from PHE units up 42.21% compared to 2009 and sales from heat exchangers up 69.18% compared to 2009. Sales from heat meters were up 22.08% from 2009 and accounted for $9.74 million in revenues for 2010.

The breakdown of revenues for the fourth quarter of 2010 was $21.64 million from PHE units and $19.33 million from heat exchangers, with sales from PHE units up 107.57% compared to 4Q09 and sales from heat exchangers up 25.06% compared to 4Q09. Sales from heat meters were up 482.29% from 4Q09 and accounted for $0.83 million in revenues for the quarter.

The following table presents the revenue contribution by percentage for each major product line in 4Q10 in comparison with 4Q09 and fiscal year 2010 in comparison with 2009:

Net Income

Net income in 2010 totaled $22.70 million ($0.68 per diluted share), up 47% from $15.44 million ($0.58 per diluted share) in 2009.

Net income in the fourth quarter totaled $6.50 million, up 122.26% from $2.92 million in 4Q09. The higher net income was driven primarily by increased sales from PHEs and PHE units. Earnings per share for 2010 increased by $0.10 per share.

Gross Profit Margin

Gross profit margin for 2010 was 35.65%, up from 35.24% in 2009. Gross profit margin for 4Q10 was 36.55%, up from 35.03% in 4Q09. The margin maintenance for 2010 is due mainly to our effective cost control and our cost-plus pricing.

Operating Expense

Operating expenses as a percentage of sales were 14.4% for fiscal year 2010 and 17.8% for Q410, compared to 13.2% for fiscal year 2009 and 22.9% for Q409. The increase in operating expenses resulted from increased sales and expansion of our business, including the hiring of more sales personnel, higher depreciation expense, training the marketing team and establishing new sales offices in more regions of China. We believe the expansion and training of our marketing team and other employees will increase sales and improve the efficiency of our operations. We will continue our tight budgetary control and cost effectiveness.

2011 Full Year Guidance

SmartHeat is announcing full year 2011 guidance of $22 – $28 million in net income on $120 – $150 million in revenues, reflecting $0.60 – $0.80 EPS.

Outlook

Mr. James Jun Wang, Chairman and Chief Executive Officer of Smart Heat Inc., commented: “We maintained the momentum from the first nine months of 2010 and delivered another set of strong results. We thank our hard working employees who are dedicated to executing our operational strategy. We are quite pleased to see the significant payback we expected to receive from investments made to expand our sales and distribution channels.”

“Government requirements to implement energy savings and emission reduction have increased the demand for our energy-saving products in all industrial sectors. We are optimistic about taking advantage of economic development in West China and urbanization trends throughout the country even though China is experiencing inflation and is responding to currency and inflationary pressures. Furthermore, we plan to reap the benefits of our expansion into western China and are excited about the addition of the German heat pump manufacturer GWP, which, with our expansion into nuclear energy products, will be a valuable addition to our clean energy business portfolio.” concluded Mr. Wang.

Investor Conference Call Instructions:

SmartHeat management will host an earnings conference call to discuss its 2010 financial results and 2011 outlook.

Date and time: 8:30 a.m. U.S. Eastern Daylight Saving Time, March 15, 2011

U.S. toll free number: +1 866-800-8648

International direct dial-in: +1-617-614-2702

Conference passcode: 163 032 65

About SmartHeat Inc.

Founded by James Jun Wang, a former executive at Honeywell China, SmartHeat Inc. (www.smartheatinc.com) is a NASDAQ Global Market listed (NASDAQ: HEAT) U.S. company with its primary operations in China. SmartHeat is a market leader in China’s clean technology energy savings industry. SmartHeat manufactures heat exchangers, custom plate heat exchanger units (PHE Units) and heat meters. SmartHeat’s products directly address air pollution problems in China where massive coal burning for cooking and heating purposes is the only source of economical heat energy in China. With broad product applications, SmartHeat’s products significantly reduce heating costs, increase energy use, reduce air pollution, and have broad applications. SmartHeat’s customers include global Fortune 500 companies as well as municipalities and industrial/residential users. China’s heat transfer market is currently estimated at approximately $2.4 billion with double-digit annual growth according to the China Heating Association.

Safe Harbor Statement

All statements in this press release that are not historical are forward- looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ from the company’s expectations. SmartHeat’s actual results may differ from its projections. Further, preliminary results are subject to normal year-end adjustments. You are cautioned not to place undue reliance on any forward-looking statements in this press release as they reflect SmartHeat’s current expectations with respect to future events and are subject to risks and uncertainties that may cause actual results to differ materially from those contemplated. Potential risks and uncertainties include, but are not limited to, the risks described in SmartHeat’s filings with the Securities and Exchange Commission.

Tilman J. Fertitta to Commence Cash Tender Offer for McCormick & Schmick’s (MSSR) Seafood Restaurants

UQM Technologies (UQM) Streamlines its Structure to Focus on Future Growth and Efficiency

Apr. 1, 2011 (Business Wire) — UQM Technologies, Inc. (NYSE Amex: UQM), a developer and manufacturer of power-dense, high-efficiency electric motors, generators and power electronic controllers, is streamlining the company to better prepare for growth and success while improving efficiency.

Previously, UQM operated as two businesses, focused on production and product development. It will now function as one company with efforts aligned into four core functions:

• Finance – This group will oversee all finances and business functions, including human resources and administration. It will be led by Donald A. French, Treasurer and Chief Financial Officer.
• Operations – This group will include the manufacturing and procurement functions for all high-volume and prototype systems. It will be led by Ron Burton, Senior Vice President of Operations.
• Engineering – This group will include both production and development engineering. It will be led by Jon Lutz, Vice President of Engineering.
• Sales and Business Development – This group will focus on developing new business opportunities, potential market segments, product and regional expansion and investigating potential strategic partnerships. An executive to lead this team will be announced at a later date.

Each leader of these new core areas will report directly to Mr. Ridenour, President and Chief Executive Officer.

“This organizational change is key to our transition to high-volume production of our electric-drive systems and to developing new customers,” said Mr. Ridenour. “This new alignment of resources enables the company to operate more efficiently and helps UQM to focus on the development of next generation products, continue to improve manufacturing processes and reduce cost and more aggressively pursue additional sales of our production-validated electric-propulsion systems.”

Over the past five weeks, UQM has announced business agreements to supply Audi, Rolls-Royce and Saab with electric propulsion systems for pre-production test fleets. The company has a validated production line capacity of 40,000 units per year to supply CODA Automotive and other automotive OEM companies. UQM also supplies Proterra Inc. with electric propulsion systems to power their composite transit buses, as well as Electric Vehicles International (EVI) for its medium-duty delivery vehicles.

“The electrification of the vehicle marketplace is happening at a rapid rate, and our significant investments throughout the company make us well-positioned to deliver the value, innovation and quality that our customers expect,” continued Ridenour. “Our realignment allows us to continue doing what we do, only better – delivering high-quality, competitive products for the fast growing electric vehicle and hybrid markets.”

The company recently relocated to a new 130,000 square foot, 30-acre facility in Longmont, Colorado. The facility houses a fully validated production process that meets Advanced Product Quality Planning (APQP) automotive standards and is capable of high-volume, quality production, including successful programs for major automotive OEMs.

About UQM Technologies, Inc.

UQM Technologies is a developer and manufacturer of power-dense, high-efficiency electric motors, generators and power electronic controllers for the automotive, aerospace, military and industrial markets. A major emphasis for UQM is developing products for the alternative-energy technologies sector, including propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles, under-the-hood power accessories and other vehicle auxiliaries. UQM headquarters, engineering, product development center and manufacturing operation are located in Longmont, Colorado.

Please visit www.uqm.com for more information.

This Release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These statements appear in a number of places in this Release and include statements regarding our plans, beliefs or current expectations, including those plans, beliefs and expectations of our officers and directors with respect to, among other things, orders to be received under our supply agreement with CODA Automotive, our ability to successfully expand our manufacturing facilities, and the continued growth of the electric-powered vehicle industry. Important Risk Factors that could cause actual results to differ from those contained in the forward-looking statements are contained in our Form 10-Q filed February 1, 2011, which is available through our website at www.uqm.com or at www.sec.gov.

UQM Technologies, Inc.

Donald A. French, 303-682-4918

or

BPC Financial Marketing

John Baldiserra, 800-368-1217

Radio One, Inc. (ROIAK) Announces New Senior Credit Facility

Optimer Pharmaceuticals (OPTR) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

U.S. Court Grants LogMeIn’s (LOGM) Motion for Summary Judgment of Non Infringement in Patent Infringement Case

WOBURN, Mass., April 1, 2011 (GLOBE NEWSWIRE) — LogMeIn, Inc. (Nasdaq:LOGM), a provider of SaaS-based, remote-connectivity solutions, today announced that the United States District Court for the Eastern District of Virginia granted LogMeIn’s motion for summary judgment of non infringement in the case brought by 01 Communique. The court indicated a written order will follow. The court indicated it has removed the May 2nd trial from the case calendar.

About LogMeIn, Inc.

LogMeIn (Nasdaq:LOGM) makes it easy to control and access remote devices — desktops, laptops, point-of-sale systems, medical devices, smartphones and more — from any internet-connected computer, including an iPad™, iPhone® and digital displays. Over 11 million active users have connected more than 125 million devices using LogMeIn for business productivity, personal mobility and IT support. LogMeIn is based in Woburn, Massachusetts, USA, with offices in Australia, Hungary, the Netherlands, and the UK.

The LogMeIn, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6574

This press release contains forward-looking statements with respect to LogMeIn and the patent infringement lawsuit that involve risks and uncertainties. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including uncertainties or difficulties in defending the lawsuit, including the potential of appeal of the granting of the summary judgment motion, as well as other factors described in LogMeIn’s Annual Report on Form 10-K for the year ended December 31, 2010, and its most recent quarterly report filed with the SEC. LogMeIn disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

LogMeIn is a registered trademark of LogMeIn in the U.S. and other countries.

iPhone and iPad are trademarks of Apple, Inc. in the U.S. and other countries around the world.

CONTACT: Media contacts:
         Craig VerColen
         press@logmein.com
         +1-617-599-2180